InvestorsHub Logo
Followers 10
Posts 4272
Boards Moderated 0
Alias Born 11/12/2012

Re: arvitar post# 140914

Tuesday, 10/23/2018 7:08:29 PM

Tuesday, October 23, 2018 7:08:29 PM

Post# of 146240

Ironically, it represents a more significant effort by Seymour to communicate to investors than at any time during his previous few years as CEO.


That part should be pinned.

I think we have to delineate technical vs. financial accomplishments. As head scientist and resident "genius", the scientific stuff was Dr. Diwan's responsibility, That includes picking the 'cide to develop, setting up the pre-IND meeting, and doing the IND enabling tox. I blame Diwan, not Seymour for that.

The failure to negotiate the license was as much Dr. Seymour's fault as Dr. Diwan's -- they are on opposite sides of that negotiation. Of course a sane biotech that wasn't designed to screw over shareholders wouldn't have been set up in a way that requires these negotiations.

Finally, Dr. Seymour's main purpose in life was to raise money when the share price was at $3, or at least at $2. He failed to do so, and now we are all watching the clock as NNVC circles around the drain.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News